Industry titan DaVita deems assessment "disappointing"
By Steve Raabe
The Denver Post
Posted: 11/10/2010 01:00:00 AM MST
Updated: 11/10/2010 01:49:32 AM MST
The ProPublica article on the U.S. dialysis industry is misleading and misinterprets data, said officials of Denver-based DaVita Inc., the nation's largest dialysis provider.
While the mortality rate of U.S. kidney patients is higher than in some other industrialized countries, the rate has steadily fallen, and patients generally receive high-quality care, said Dr. Allen Nissenson, chief medical officer of DaVita.
Nissenson said the article is "profoundly disappointing. It took some information and did not clearly explain it or (present) it in a way that people could understand the issues."
DaVita operates 1,582 dialysis clinics, with a workforce of about 34,000, including 749 in Colorado.
The firm last year moved its corporate headquarters from El Segundo, Calif., to metro Denver, becoming Colorado's ninth Fortune 500 company.
DaVita plans to begin construction next year on a $101 million headquarters building in the Central Platte Valley at the west end of the 16th Street Mall.
DaVita officials noted that the mortality rate of U.S. dialysis patients has fallen by 8.5 percent since 2002, from 231.3 per 1,000 patients that year to 211.7 in 2007, the most recent year reported by the U.S. Renal Data System.
The U.S. has comparatively higher death rates, Nissenson said, for two reasons: Patients tend to come into the dialysis system already sicker than those in other countries, and the U.S. has higher proportions of blacks and Latinos